University of Wisconsin FluGen snaps up $12 mln Series A

FluGen Inc., a biotechnology company developing a novel “universal” influenza vaccine, has completed a $12 million Series A financing. Venture Investors LLC, the Wisconsin Alumni Research Foundation (WARF), the State of Wisconsin Investment Board, and other new investors participated in this first institutional financing of the company, along with many of FluGen’s existing investors led […]